Dow Jones futures were higher ahead of Tuesday’s open, as the banking crisis continues to escalate, with two large bank failures in recent days — SVB Financial (SIVB) and Signature Bank (SBNY). Meanwhile, Schwab stock plunged 11% Monday on growing liquidity fears, while Tesla shares climbed after the company ramped up hiring at its Gigafactory in Texas. And GitLab crumbled 36% late on earnings.
X
Financial Crisis
The SPDR S&P Regional Banking ETF (KRE) dived more than 12% Monday, even after cutting some losses. That’s on top of the 16% loss it had last week.
Regional bank First Republic (FRC) crashed nearly 62%. KeyCorp (KEY) dived 27.3%. And Western Alliance (WAL) crumbled 47%.
Charles Schwab (SCHW) plunged on fears that the largest U.S. brokerage will need to sell some of its bond holdings to cover deposit withdrawals. Schwab stock’s drop at its worst point on the day would be the largest percentage decrease on record (based on data that goes back to Sept. 23, 1987), according to Dow Jones.
Major U.S. banks weren’t spared from the selling either, with Bank of America (BAC), JPMorgan Chase (JPM) and Wells Fargo (WFC) falling 5.8%, 1.8% and 7.1%, respectively.
CPI Inflation Report, Earnings
On the economic front, eyes will be on the consumer price index on Tuesday. The CPI is expected to rise 0.4%, both overall and excluding food and energy. That would bring the headline CPI inflation rate down to 6% from 6.1% in January, with the core inflation rate easing to 5.5% from 5.6%.
Wall Street suddenly sees a solid chance that the Federal Reserve will pause its rate-hiking campaign at next week’s meeting as the failure of three banks stokes concern about broader financial-sector stress.
Half-point moves are now off the table — just a week after Fed chair Jerome Powell signaled that policymakers were ready to reaccelerate rate hikes at next week’s meeting from February’s quarter-point pace.
Now a sharp dive in Treasury yields is signaling sudden doubts about the strength of the economy. Even if the Fed doesn’t pause next week, markets are betting that rate cuts are around the corner.
On the earnings front, GitLab (GTLB) toppled 36% in extended trade after the company’s weaker-than-expected revenue guidance.
Earnings continue trickling out at the tail end of the season this week. Among them are Academy Sports & Outdoors (ASO), Adobe (ADBE), Dollar General (DG), FedEx (FDX), Five Below (FIVE) and Lennar (LEN).
Stock Market Today
On Monday, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 lost 0.15%. The tech-heavy Nasdaq composite climbed 0.45% in a day of volatile trading.
Electric-vehicle giant Tesla (TSLA) traded up 0.6% Monday. Among Dow Jones stocks, Apple (AAPL) rose 1.3% and Microsoft (MSFT) climbed 2.1% in today’s stock market action.
Social media giant Meta Platforms (META), IBD Leaderboard watchlist stock Palo Alto Networks (PANW) and New Relic (NEWR) — as well as Dow Jones stocks Nike (NKE) and Salesforce (CRM) — are among the top stocks to watch in the new stock market correction.
Palo Alto is an IBD Leaderboard watchlist stock. New Relic was recently an IBD Stock Of The Day. And Nike was featured in this week’s Stocks Near A Buy Zone column.
3 Top Growth Stocks To Buy And Watch In The Current Stock Market Correction
Dow Jones Futures Today: Oil Prices, Treasury Yields
Ahead of Tuesday’s opening bell, Dow Jones futures rose 0.5%, and S&P 500 futures moved up 0.6%. Nasdaq 100 futures were up 0.65% vs. fair value. Remember that overnight action in Dow Jones futures and elsewhere doesn’t necessarily translate into actual trading in the next regular stock market session.
The 10-year U.S. Treasury yield dived to 3.51% Monday, as safe haven trade drove bonds sharply higher following the SVB collapse. Oil prices sold off Monday after Friday’s brief bounce. West Texas Intermediate futures slid nearly 3%, trading below $75 a barrel.
What To Do In The New Stock Market Correction
Now is an important time to read IBD’s The Big Picture column with the stock market trend back in a “market in correction” after sharp losses in recent sessions.
Friday’s Big Picture column commented, “IBD changed its market outlook to ‘uptrend under pressure’ Thursday. And after Friday’s sell-off we’ve cut our outlook further, to ‘market in correction.’ This requires investors to avoid any stock purchases and pivot to defensive trading, such as taking profits and cutting losses short.”
(Check out IBD Stock Lists like the IBD 50 and Stocks Near A Buy Zone, for additional stock ideas.)
Five Dow Jones Stocks To Watch Now
Dow Jones Stocks To Watch: Nike, Salesforce
Since bottoming on Oct. 3, Nike shares have rallied as much as 59% to their recent high at 131.31. Now the stock is consolidating within a flat base that offers a 131.41 buy point, according to IBD MarketSmith pattern recognition.
Amid recent weakness, the stock is below its 50-day moving average, a key benchmark. A decisive retake would be bullish for the base-building prospects, carving the right side of the pattern. The relative strength line is also holding up well during the rapidly-developing stock market correction.
In recent weeks, Dow Jones leader Salesforce showed big upside strength after strong fourth-quarter results. But those gains have mostly disappeared amid the recent market weakness, and now the stock is back below a 178.94 cup-with-handle entry. Still, the stock’s recent strength is a reason to monitor the software leader in the coming sessions.
Top Stocks To Watch: Meta, Palo Alto, New Relic
Facebook-parent Meta Platforms is quietly building a flat base with a 197.26 buy point following an earnings-fueled price surge in February. Shares are about 8% away from the latest buy point, as they rose 0.8% Monday.
Back story: Like social media rivals, Meta is struggling due to a sharp reduction in advertising revenue as clients squirm over macroeconomic concerns, recession fears and higher interest rates. This is happening as it spends billions on a risky bet to build the “metaverse,” a virtual reality world that has yet to take hold.
IBD Leaderboard watchlist stock Palo Alto Networks continues to trade quietly in a handle after the stock’s 12.5% surge on Feb. 22. Shares remain within striking distance of a base’s 192.94 buy point. Bullishly, the stock’s relative strength line is at new highs, as the stock sharply outperforms the market averages. PANW stock traded up 0.1% Monday.
Back story: On Feb. 21, the cybersecurity giant announced good results for the January-ended quarter that saw earnings hit $1.05 a share, up 81% vs. a year earlier, on a 26% jump in revenue to $1.7 billion.
Recent IBD Stock Of The Day, New Relic, is working on a flat base with a 80.98 buy point in the aftermath of the Feb. 8 earnings-fueled surge. The RS line is holding up for now. NEWR stock was down 0.7% Monday.
Back story: New Relic provides a cloud-based suite of software products that enables organizations to collect, store and analyze massive amounts of data in real time. Customers gain increased visibility into their enterprise software to help make data-driven decisions.
Join IBD experts as they analyze leading stocks in the current stock market correction on IBD Live
Tesla Stock
Tesla stock climbed 0.6% Monday, as it continues see some support around its 50-day moving average line. Shares closed Monday around 55% off their 52-week high.
On Tuesday, weekly China EV insurance registration data could be an important gauge for Tesla demand in the world’s largest EV market, which is in the midst of a huge price war started by Tesla.
Dow Jones Leaders: Apple, Microsoft
Among Dow Jones stocks, Apple shares rose 1.3% Monday, snapping a two-day losing streak and finding support at the long-term 200-day line.
Microsoft shares bullishly regained its 200-day line during Monday’s 2.1% jump. The stock is still around 20% off its 52-week high after recent declines.
YOU MAY ALSO LIKE:
Top Growth Stocks To Buy And Watch
Learn How To Time The Market With IBD’s ETF Market Strategy
Find The Best Long-Term Investments With IBD Long-Term Leaders
MarketSmith: Research, Charts, Data And Coaching All In One Place
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
